Multimaterial and Multidimensional Bioprinting in Regenerative Medicine: Advances, Limitations, and Future Directions
- PMID: 40465211
- DOI: 10.1002/adhm.202500475
Multimaterial and Multidimensional Bioprinting in Regenerative Medicine: Advances, Limitations, and Future Directions
Abstract
3D bioprinting has been advanced from creating simple, static structures with single materials to sophisticated multimaterial and multidimensional designs. This evolution has improved printing precision, the range of application and dynamic functionality. Multimaterial and multidimensional bioprinting represent significant advancements in regenerative medicine. By integrating a range of materials and employing diverse printing techniques, these approaches address the limitations of single-material and fixed-dimension methods, thereby overcoming the constraints of traditional, uniform complexity. Multimaterial bioprinting fabricates additive manufacturing structures simultaneously with materials vary in composition and mechanical strength, which increases the complexity in biomedical applications. Meanwhile, multidimensional bioprinting involves incorporating additional dimensions (such as time or space) into printing process, which allows for dynamic configuration transformations and functional responses. Here, the basic concepts and components are summarized of multimaterial and multidimensional bioprinting, the medical adaptation is discussed and the advantages, challenges as well as future perspectives of current approaches are analyzed. Moreover, this review provides perspective on multimaterial and multidimensional bioprinting, and highlights new opportunities in regenerative medicine tissue engineering, particularly in bone tissue engineering bioprinting.
Keywords: 4D printing; multidimensional bioprinting; multimaterial bioprinting; tissue engineering; tissue regeneration.
© 2025 Wiley‐VCH GmbH.
Similar articles
-
Advances in Regenerative Medicine, Cell Therapy, and 3D Bioprinting for Corneal, Oculoplastic, and Orbital Surgery.Adv Exp Med Biol. 2025;1483:69-114. doi: 10.1007/5584_2025_855. Adv Exp Med Biol. 2025. PMID: 40131704 Review.
-
3D bioprinting approaches for musculoskeletal interfaces in tissue engineering.Int J Pharm. 2025 Sep 15;682:125939. doi: 10.1016/j.ijpharm.2025.125939. Epub 2025 Jul 6. Int J Pharm. 2025. PMID: 40628344 Review.
-
3D bioprinting in tissue engineering: current state-of-the-art and challenges towards system standardization and clinical translation.Biofabrication. 2025 Aug 7;17(4). doi: 10.1088/1758-5090/ade47a. Biofabrication. 2025. PMID: 40513614 Review.
-
Genetic and bioactive functionalization of bioinks for 3D bioprinting.Bioprocess Biosyst Eng. 2025 Sep;48(9):1421-1449. doi: 10.1007/s00449-025-03180-y. Epub 2025 May 20. Bioprocess Biosyst Eng. 2025. PMID: 40392297 Review.
-
Vat photo-polymerization 3D printing of gradient scaffolds for osteochondral tissue regeneration.Acta Biomater. 2025 Jun 15;200:67-86. doi: 10.1016/j.actbio.2025.05.042. Epub 2025 May 23. Acta Biomater. 2025. PMID: 40414264 Review.
References
-
- M. A. Heinrich, W. Liu, A. Jimenez, J. Yang, A. Akpek, X. Liu, Q. Pi, X. Mu, N. Hu, R. M. Schiffelers, J. Prakash, J. Xie, Y. S. Zhang, Small Weinh. Bergstr. Ger. 2019, 23, 1805510.
-
- X. B. Chen, A. Fazel Anvari‐Yazdi, X. Duan, A. Zimmerling, R. Gharraei, N. K. Sharma, S. Sweilem, L. Ning, Bioact. Mater. 2023, 28, 511.
-
- H. Ravanbakhsh, V. Karamzadeh, G. Bao, L. Mongeau, D. Juncker, Y. S. Zhang, Adv. Mater. 2021, 49, 2104730.
-
- Y. Tang, Y. Zhang, L. Zou, C. Sun, W. Tang, Y. Zou, A. Zhou, W. Fu, F. Wang, K. Li, Q. Zhang, X. Zhang, Biofabrication 2025, 17, 032002.
-
- J. Guo, H. Yao, X. Li, L. Chang, Z. Wang, W. Zhu, Y. Su, L. Qin, J. Xu, Bioact. Mater. 2023, 21, 175.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources